Cellebrite DI (CLBT) vs Fastly (FSLY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Fastly (FSLY) has outperformed Cellebrite DI (CLBT) over the past year, gaining 36.7% versus a loss of 36.2%. Over five years, CLBT leads with a +24.1% price change compared with -63.2% for FSLY. Cellebrite DI is the larger company by market cap ($2.71 billion vs $2.40 billion), about 1.1 times the size.
On valuation, Cellebrite DI trades at a lower forward P/E (16.1x vs 20.8x for Fastly). Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus -19.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLBT | FSLY |
|---|---|---|
| Share price | $10.77 | $14.91 |
| Market cap | $2.71B | $2.40B |
| 1-day change | -4.86% | -11.57% |
| YTD return | -40.27% | +46.46% |
| 1-year return | -36.20% | +36.66% |
| 5-year return | +24.08% | -63.21% |
| P/E ratio (TTM) | 43.08 | — |
| Forward P/E | 16.09 | 20.78 |
| EPS (TTM) | $0.25 | $-0.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $475.68M | $624.02M |
| Revenue growth (YoY) | +18.56% | +14.78% |
| Net income (latest FY) | $78.33M | $-121.68M |
| Gross margin | 84.20% | 57.08% |
| Operating margin | 13.98% | -19.07% |
| Net margin | 16.47% | -19.50% |
| 52-week high | $19.39 | $34.82 |
| 52-week low | $9.58 | $7.87 |
| Distance from 52-week high | -44.46% | -57.18% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +43.27% | +65.86% |
| Average volume | 2.35M | 6.50M |
| Shares outstanding | 251.34M | 161.20M |
| Employees | 1,285 | 1,140 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FSLY has outperformed CLBT by 72.9 percentage points over the past year.
- Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus -19.5 cents for Fastly.
About Cellebrite DI
CLBT stock →Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Technology · Computer Software: Prepackaged Software · 1,285 employees
About Fastly
FSLY stock →Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally.
Technology · Computer Software: Prepackaged Software · 1,140 employees
CLBT vs FSLY FAQ
Which is bigger, Cellebrite DI or Fastly?
Cellebrite DI (CLBT) is larger, with a market capitalization of $2.71B compared with $2.40B for Fastly (FSLY).
Which stock has performed better over the past year, CLBT or FSLY?
FSLY returned +36.66% over the past 12 months, compared with -36.20% for CLBT (price return, excluding dividends). Past performance does not predict future results.
Are Cellebrite DI and Fastly in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.